B
HALO icon

Bellecapital’s Halozyme HALO Stock Holding History

Bellecapital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,290
Closed -$210K – 140
2025
Q1 		$210K Buy
+3,290
New +$191K 0.04% 122
2021
Q1 		– Sell
-9,916
Closed -$424K – 190
2020
Q4 		$424K Sell
9,916
-1,784
-15% -$64.1K 0.14% 123
2020
Q3 		$307K Hold
11,700
– – 0.14% 122
2020
Q2 		$314K Hold
11,700
– – 0.15% 100
2020
Q1 		$210K Buy
+11,700
New +$222K 0.13% 133

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bellecapital's HALO Position: Q2 2025 in Review

Bellecapital sold out of Halozyme (HALO) in Q2 2025, closing a stake of 3,290 shares — an estimated $210K sold.

Bellecapital first reported a position in HALO in Q1 2020 and held it in 5 quarters. The position peaked at $424K in Q4 2020. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Bellecapital reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Bellecapital sold 3,290 Halozyme shares in Q2 2025, an estimated $210K.
  • Bellecapital first reported a position in Halozyme in Q1 2020 and held it in 5 quarters.
  • Bellecapital's Halozyme position peaked at $424K in Q4 2020.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Bellecapital's 13F filing for Q2 2025, filed 29 Jul 2025.